Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial

H Hanai, T Iida, K Takeuchi, F Watanabe… - Clinical …, 2006 - Elsevier
Background & Aims: Curcumin is a biologically active phytochemical substance present in
turmeric and has pharmacologic actions that might benefit patients with ulcerative colitis …

[HTML][HTML] Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo …

S Kedia, V Bhatia, S Thareja, S Garg… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To evaluate the role of oral curcumin in inducing clinical remission in patients with mild
to moderate ulcerative colitis (UC). METHODS A prospective randomized double-blind …

[HTML][HTML] Curcumin use in ulcerative colitis: is it ready for prime time? A systematic review and meta-analysis of clinical trials

S Chandan, BP Mohan, OC Chandan… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background: Curcumin, an active ingredient of the Indian herb turmeric (Curcuma longa),
has shown promising anti-inflammatory properties. Studies of its potential benefits in treating …

The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis

N Sadeghi, A Mansoori, A Shayesteh… - Phytotherapy …, 2020 - Wiley Online Library
Background and aims Curcumin has anti‐inflammatory properties. The aim of this study was
to evaluate the effect of curcumin on improvement of the disease activity in ulcerative colitis …

Curcumin for maintenance of remission in ulcerative colitis

SK Garg, V Ahuja, MJ Sankar… - Cochrane Database …, 2012 - cochranelibrary.com
Background Ulcerative colitis (UC) is a chronic inflammatory condition of the colon
characterized by episodes of disease activity and symptom‐free remission. There is paucity …

Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial

A Lang, N Salomon, JCY Wu, U Kopylov… - Clinical …, 2015 - Elsevier
Background & Aims The phytochemical compound curcumin was reported to be effective in
maintaining remission in patients with ulcerative colitis (UC). We investigated curcumin's …

[HTML][HTML] The use of curcumin as a complementary therapy in ulcerative colitis: a systematic review of randomized controlled clinical trials

MR Coelho, MD Romi, DMTP Ferreira, C Zaltman… - Nutrients, 2020 - mdpi.com
The objective of this study was to systematically review the literature to verify the efficacy and
safety of curcumin as a complementary therapy for the maintenance or induction of …

Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis—A randomized, placebo-controlled, pilot study

V Singla, V Pratap Mouli, SK Garg, T Rai… - Journal of Crohn's …, 2014 - academic.oup.com
Background and aims Curcumin, an active ingredient of turmeric with anti-inflammatory
properties, has been demonstrated to be useful in experimental models of ulcerative colitis …

Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations

MS Baliga, N Joseph, MV Venkataranganna… - Food & function, 2012 - pubs.rsc.org
Inflammatory bowel disease (IBD) comprising of ulcerative colitis (UC) and Crohn's disease
(CD) is a major ailment affecting the small and large bowel. In clinics, IBD is treated using 5 …

Curcumin therapy in inflammatory bowel disease: a pilot study

PR Holt, S Katz, R Kirshoff - Digestive diseases and sciences, 2005 - Springer
Curcumin, a natural compound used as a food additive, has been shown to have anti-
inflammatory and antioxidant properties in cell culture and animal studies. A pure curcumin …